Recent evidence has highlighted the crucial role of the IL-33/ST2 pathway in Alzheimer’s disease (AD), Parkinson’s disease (PD), and several other neurological conditions [10, 18, 19]. The gene discussed is IL33; the disease is Parkinson disease.